Ventria Bioscience Case Study

760 Words4 Pages
Scott Deeter was the president and CEO of Ventria Bioscience, a Sacramento, California-based biotechnology firm that developed an innovative process to produce pharmaceutical proteins in the seeds of genetically modified rice, which was used to create a medicine to lessen the severity of childhood diarrhea. However, Scott Deeter and Ventria faced many problems.One being that the company was unsuccesful in getting the California Secretary if Agriculture to grant them the necessary permits in order to plant the 120 acres of bioengineered rice to begin commercial-scale production. Another being that many different organizations opposed what they were doing, such as, environmentalists, food safety activists, consumer advocates, and rice farmers. There is also a risk of contamination, and genetically altered plant possibly cross-breeding with wild plants. 2.) What groups have a stake in Ventria’s actions? Identify the relevant stakeholders and for each, state its interests and sources of power. Scott Deeter, the President and CEO of Ventria Bioscience was a stakeholder, along with Dr. Raymond Rodriguez, the founder of Ventria Bioscience, and a molecular biologist on the faculty of the University of California-Davis. In his search for funding, Rodriguez approached Dr.…show more content…
Without doing this, they have no room to grow. With no effort to reach out to the community, how will they market themselves? If they don’t persuade government agencies then they won’t have regulations to proceed with their business. I do not believe that would benefit Ventria in any way. If dialogue and political action are unsuccessful, they should then figure out a way to make the opposers (environmentalists, food safety activists, consumer advocates, and rice farmers) benefit in some way, especially by following all of the regulations. I think that would definitely help their
Open Document